The overarching goal of our Institute for the Brain and Cognitive Sciences Seed Grant is to understand the role of endogenous cannabinoid (eCB) signaling in the regulation of locus coeruleus activity and stress-induced responses. It is well known that stress (e.g., predator threat) activates norepinephrine-containing neurons in the locus coeruleus (LC) to promote anxiety-like responses. However, the molecular mechanisms that terminate the effects of stress are unclear. While LC-NE neurons express the inhibitory Gi-coupled cannabinoid 1-type receptor (CB1R), it remains unknown if CB1R and/or the release of endogenous cannabinoids (eCB) in the LC region can play a role in stress regulation. Our overarching hypothesis is that threat activates LC-NE neurons and stimulates eCB release, thus activating CB1R on stress-responsive neurons to attenuate behavioral and physiological features of the acute stress response. First, we will use a new eCB fluorescent biosensor and fiber photometry to determine the natural eCB dynamics in the LC region during acute stress in awake, behaving mice. Second, we will use slice electrophysiology and pharmacology to determine if activation of CB1R will blunt stress-related LC excitability. Third, we will use a viral genetic strategy for selective elimination of CB1R in LC-NE neurons to determine if loss of CB1R will exacerbate stress-induced anxiety-like behavior and physiological responses. Taken together, our work will take a multidisciplinary approach to uncover how eCB signaling influences a prominent, yet understudied neuromodulatory system and its regulation of stress. PI, Natale Sciolino. Co-PIs: Daniel Mulkey, John Salamone, Melissa Boucher.